Attenuated Getah virus confers protection against multiple arthritogenic alphaviruses
PLOS Pathogens · 2024
DOI: 10.1371/journal.ppat.1012700 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2024. Verfasst von Zhiwen Jiang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Sanya Institute of Nanjing Agricultural University, Academy for Advanced Interdisciplinary Studies, Jiangsu Engineering Laboratory of Animal Immunolo…. Hauptthemen laut MEDLINE: Alphavirus, Alphavirus Infections, Vaccines, Attenuated, Viral Vaccines. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Project of Sanya Yazhou Bay Science and Technology City, Estonian Research Council.
Abstract (Originalsprache)
Alphaviruses are important arthropod-transmitted pathogens of humans and livestock. Getah virus (GETV) is an arthritogenic alphavirus that causes disease in horses and piglets; it also poses a potential threat to humans. A live attenuated vaccine candidate named GETV-3ΔS2-CM1, harbouring a deletion in nonstructural protein 3 and substitutions in the capsid protein, is genetically stable and exhibits robust immunogenicity. It was shown to confer passive protection to piglets born to immunized sows. In mice, a single dose of GETV-3ΔS2-CM1 protected against infection with different strains of GETV, Semliki Forest virus, Ross River virus, o’nyong’nyong virus, chikungunya virus, and Barmah Forest virus. Chimaeras based on the GETV-3ΔS2-CM1 backbone maintained both the attenuated phenotype and high immunogenicity. The safety, efficacy, and ability to induce protection against multiple alphaviruses highlights the potential of GETV-3ΔS2-CM1 and chimaeras using this backbone as promising vaccine candidates. By contributing simultaneously to the wellbeing of animals and humans, our universal next generation vaccine strategy helps to achieve "One Health" goals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Sanya Institute of Nanjing Agricultural University, Academy for Advanced Interdisciplinary Studies, Jiangsu Engineering Laboratory of Animal Immunology, Institute of Immunology and College of Veterinary Medicine, Nanjin…
- Institute of Bioengineering, University of Tartu, Tartu, Estonia.
- MOA Key Laboratory of Animal Virology, Zhejiang University, Hangzhou, China.
- Institute of Technology, University of Tartu, Tartu, Estonia.
ORCID-Profile: Zhiwen Jiang, Shuo Su
Förderung
- National Key Research and Development Program of China
- Project of Sanya Yazhou Bay Science and Technology City
- Estonian Research Council
Zitieren
APA
Jiang, Z., Merits, A., Qin, Y., Xing, G., Zhang, L., Chen, J., Wang, N., Varjak, M., Zhai, X., Li, D., Song, W., & Su, S. (2024). Attenuated Getah virus confers protection against multiple arthritogenic alphaviruses. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1012700
Vancouver
Jiang Z, Merits A, Qin Y, Xing G, Zhang L, Chen J, et al. Attenuated Getah virus confers protection against multiple arthritogenic alphaviruses. PLOS Pathogens. 2024. doi:10.1371/journal.ppat.1012700
BibTeX
@article{Jiang2024,
author = {Jiang, Zhiwen and Merits, Andres and Qin, Ying and Xing, Gang and Zhang, Letian and Chen, Jie and Wang, Ningning and Varjak, Margus and Zhai, Xiaofeng and Li, Dongyan and Song, Wanjie and Su, Shuo},
title = {Attenuated Getah virus confers protection against multiple arthritogenic alphaviruses},
journal = {PLOS Pathogens},
year = {2024},
doi = {10.1371/journal.ppat.1012700}
}
EUVIMED